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ABSTRACT:  
Objective: Psychological factors increase the risk to develop post-infectious irritable bowel syndrome 
(PI-IBS), but the mechanisms involved are unclear. As stress affects the immune system, we 
investigated the potential interaction between psychological factors, the immune response against 
infectious gastroenteritis (IGE) and the development of IGE and PI-IBS in a large cohort exposed to 
contaminated drinking water. 
Design: 18620 people exposed to contaminated drinking water (Norovirus, Giardia lamblia, 
Campylobacter jejuni) were invited to participate in a prospective controlled cohort study. They were 
asked to complete questionnaires assessing demographic, psychological and clinical data during the 
outbreak and one y ar later. At both time points, in-depth immune function (peripheral blood and 
rectal biopsies) was studied in a subgroup of subjects. 
Results: 1379 subjects completed the questionnaires during the outbreak, of which 271 developed 
IGE. Risk factors for IGE included younger age, pre-existing dyspepsia-like symptoms, anxiety and 
drinking contaminated tap water. Anxiety scores before the outbreak inversely correlated with IL2-
expressing CD4+Tcells (r=0.6, p=0.01, n=23). At follow-up, 34 of 172 (20%) IGE subjects developed IBS 
compared to 24/366 exposed participants (7%, p<0.0001, χ2 test). A Th2 cytokine phenotype at time 
of infection was associated with increased risk for PI-IBS 1 year later. Except for increased B cell 
numbers, no evidence for systemic or rectal mucosal immune activation in PI-IBS was demonstrated 
at follow-up.  
Conclusion: Our study shows that the increased risk of patients with psychological co-morbidity to 
develop PI-IBS may partly result from an increased susceptibility to develop IGE, possibly resulting 
from a Th2-immune bias. 
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SUMMARY BOX: 
What is already known about this subject: 
- Up to 30% of individuals develop PI-IBS following infectious gastroenteritis 
- Psychological factors increase the susceptibility to develop PI-IBS 
- Psychological stress alters the T helper 1 and T helper 2 (Th1/Th2) immune balance 
What are the new findings:  
- Anxiety and somatization are risk factors to develop IGE 
- Psychological factors, in particular anxiety and somatization, increase the risk to develop PI-
IBS partly by a direct effect and partly indirect via increased susceptibility to develop IGE  
- Anxiety and depression at the time of infection may alter the Th1/Th2 immune balance, 
predisposing to PI-IBS   
- Except for increased B cell numbers, there was no evidence for persistent immune activation 
in blood or rectal biopsies of PI-IBS  
How might it impact on clinical practice in the foreseeable future? 
- Our results provide further insight in the pathogenesis of PI-IBS, underscoring the impact of 
psychological factors  
- The absence of inflammation in PI-IBS suggests that anti-inflammatory treatment with agents 
such as mesalazine are unlikely to be effective 
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INTRODUCTION:  
Acute infectious gastroenteritis (IGE) is a well-defined risk factor to develop irritable bowel 
syndrome (IBS), with 8-31% of patients developing post-infectious IBS (PI-IBS) (1-10). To date, 
persistent mucosal microscopic inflammation is proposed to underlie abnormal neuromuscular 
function contributing to altered bowel habits and increased abdominal pain (11). Increased number 
of mononuclear cells and higher levels of IL1β mRNA have indeed been reported in rectal biopsies 
collected 3 months to 1 year after IGE (12;13). In line, 3 months after a Campylobacter infection, 
Dunlop et al. (2) showed a small increase in enterochromaffin cells in PI-IBS patients compared to 
infected subjects who did not develop IBS. However, the number of lamina propria T cells was higher 
in patients with PI-IBS and post-infected controls compared to healthy volunteers. Moreover, no 
differences in T lymphocytes, mast cells or pro-inflammatory cytokines were detected between PI-IBS 
patients and infected control subjects three years after a Salmonella infection, although only PI-IBS 
patients were hypersensitive to rectal distention (14). Hence, the evidence supporting the hypothesis 
that chronic microscopic inflammation or immune activation is involved in PI-IBS is rather limited, 
confined to small patient numbers and mostly based on biopsies collected 3-4 months after the 
episode of IGE, and thus clearly deserves further study. Of note, the severity of the insult to the 
mucosa differs significantly between pathogens, most likely explaining why some studies still report 
inflammatory changes after 3-6 months and others do not. For example, Campylobacter jejuni 
produces a severe insult with mucosal ulceration while viruses rather produce a more transient 
inflammation without ulcerations. The risk to develop PI-IBS is not only determined by the nature of 
the pathogen, the severity of the infection, age and gender, but also by psychological factors (15). 
Anxiety, depression and fatigue are identified as risk factors for PI-IBS (16;17). Correspondingly, 
patients with a history of anxiety and depression have impaired recovery of PI-IBS during a six to 
eight year period of follow-up (17;18). How psychological factors may increase the risk to develop PI-
IBS however remains unclear. Of interest, it is becoming increasingly clear that brain-gut interactions 
may significantly modulate the intestinal immune system, and thus the immune response to a 
pathogen. Chronic psychological stress impairs the immune system by altering patterns of cytokine 
secretion, thereby increasing the vulnerability to infections (19;20). For example, chronic 
psychological stress in rats alters the immune response from antigen-induced oral tolerance to 
sensitization with a subsequent antigen-induced increase in inflammatory cells and mucosal 
permeability (21). Likewise, chronic stress alters the Th1/Th2 balance (21;22) and leads to an 
accumulation of myeloid-derived suppressor cells in the peripheral blood and bone marrow 
associated with immunosuppression (23).  Moreover, chronic stress in mice activates the IL-10/STAT3 
axis, thereby suppressing the production of pro-inflammatory cytokine IL-12 and inducing a shift of 
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Th1/Th2 cytokines toward a Th2 predominance (24). Interestingly, a decreased Th1 immune 
response has recently been shown to lead to increased susceptibility of mice to infection with the 
enteropathogenic Escherichia coli (25). Based on these findings, we hypothesized that psychological 
factors may increase the risk to develop PI-IBS by modulation of the immune response towards the 
gastrointestinal infection.  
In December 2010, two small villages in Belgium (Hemiksem and Schelle) suffered from a 
large community-wide multi-pathogen outbreak of gastroenteritis due to contamination of the tap 
water with water from a small creek (26). At least 18000 local residents were exposed to this 
contaminated water supply (26). In the present study, we aimed 1. to explore the potential 
relationship between psychological factors, the immune response in the acute infectious phase and 
the risk to develop infectious gastroenteritis and/or PI-IBS; and 2. to study in depth the potential role 
of persistent immune activation in those patients who developed PI-IBS. To this end, data were 
prospectively collected using questionnaires evaluating demographics and psychological data, 
exposure to tap water, bowel habits before and during the outbreak. Additionally, clinical symptoms 
and immune activation were assessed by validated questionnaires and quantification of cytokine 
expression in (stimulated) peripheral blood mononuclear cells, in plasma and in rectal biopsies 
respectively in the acute phase of the infection and after 1 year.  
 
MATERIAL AND METHODS: 
An epidemic outbreak of IGE occurred in Hemiksem and Schelle (Belgium) between December 6 and 
9 in 2010 by contamination of the municipal tap water with local creek water as reported by the 
Local Health Authority (26). Although not officially established, the contamination was most likely 
caused by a misconnection of hoses by fireman during fire extinction. From December 6 onwards, 
the 18 620 inhabitants of both villages were exposed to contaminated water before being alarmed at 
December 9 by the Local Health Authority. From December 9 onwards, the population was advised 
to stop drinking tap water. At December 10, a task force was set up in our unit to study the 
epidemiology and long-term outcome of the outbreak. The study protocol was approved by the 
Ethics Committee of the University Hospitals Leuven and all patients gave informed consent.  
 
Study design:  
In the acute phase (within 2 weeks), 603 subjects who consulted their general physician because of 
IGE were approached by phone. This subset of patients underwent a standardized interview, filled 
out questionnaires (details below) and was approached to provide blood samples for PBMC isolation, 
faecal samples and rectal biopsies. Based on questionnaires, data were collected on demographics 
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(age, gender), exposure to tap water, bowel habits before and during the outbreak (ROME-III and 
GSRS questionnaires) and IGE characteristics, including onset of symptoms, duration of diarrhea, 
severity of abdominal discomfort and use of antibiotics. Moreover, to assess their psychological 
profile, subjects were asked to fill out the Hospital Anxiety and Depression Scale (HADS) based on 
how the subject felt 2 weeks before the outbreak and the Patient Health Questionnaire (PHQ-15) 
based on how the subject felt 4 weeks before the infection. Demographic data on the different 
recruitment strategies are reported in supplemental Table 3. To avoid the possibility that gastro-
intestinal symptoms at the time of infection influenced recall somatization scores, we modified the 
PHQ-15 by excluding three gastrointestinal items to create the PHQ-12 Somatic Symptom (PHQ-12 
SS) scale (27). In addition, all households (n=7711) of the 2 affected villages were contacted by 
mailing within 3 months after the outbreak. Subjects were invited to participate in our study and to 
complete questionnaires as described above. Subjects were excluded when younger than 18 years, if 
they had pre-existing IBS, if symptoms of IGE started outside the 2 week period following the first 
day of drinking water contamination and if the Rome III questionnaire was incompletely answered. 
One year after the outbreak, all subjects who participated previously were re-contacted to assess the 
development of PI-IBS and were asked to complete the following questionnaires: ROME-III, GSRS, 
HADS and PHQ-12. In addition, patients were asked to provide blood samples for PBMC isolation, 
faecal samples and rectal biopsies. 
 
Outcome measure / definitions:  
IGE was defined as a period of self-reported acute gastrointestinal discomfort within 2 weeks after 
tap water contamination. The severity of diarrhea was classified as follows (28): Classic IGE was 
defined as passage of three or more unformed stools per 24 h with at least one accompanying 
symptom (nausea, vomiting, abdominal cramps or pain, fever, blood in stools). Moderate IGE was 
defined as passage of one or two unformed stools with at least one additional symptom. Mild IGE 
was defined as passage of one or two unformed stools without additional symptoms. Controls (no-
IGE) were subjects who were exposed but did not report symptoms of IGE. The severity of abdominal 
cramping and abdominal pain was scored as none, mild, moderate or severe. IBS and the different 
IBS subtypes were diagnosed according to the ROME III criteria (http://www.romecriteria.org/ 
assets/pdf/19_RomeIII_apA_885-898.pdf). Subjects who reported IBS symptoms or had been 
diagnosed with IBS prior to December 6th 2010 were excluded from the study. The incidence of 
dyspepsia-like symptoms was based on 5 GSRS questions, namely epigastric pain and discomfort, 
sucking sensation in the epigastrium, nausea, bloating and regurgitation. A subject was considered as 
dyspeptic when the summated score on these questions is larger than 4. Finally, a total HADS anxiety 
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or depression score from 0 to 7 was considered normal, 8 to 10 as borderline while scores above 10 
were considered to be abnormal (29;30). 
Statistical analysis, gene expression studies, PBMC immune-phenotyping and cytokine analysis in 
plasma and in supernatants of stimulated PBMCs are described in supplementary Material and 
Methods. 
RESULTS:    
Characterization of patient cohort: 
A. Early phase 
Patient cohort 
Between December 6
th
 and 9
th
 2010, 18620 residents in 7711 households in Hemiksem and 
Schelle were exposed to contaminated tap water and asked to participate in our study. 1379 subjects 
completed the questionnaires of which 411 individuals were excluded (Flowchart Fig. 1).  
Of the 968 eligible subjects, 271 (28%) reported IGE: 62% presented with classic IGE, 19% 
with moderate IGE and 19% with abdominal symptoms but without diarrhea (IGE w/o diarrhea). The 
number of IGE cases followed a steep incline from December 6 to 8
th
 and peaked on December 8
th
 
(Fig. 2). Other main IGE symptoms included nausea (reported by 54%), vomiting (61%), abdominal 
cramping (55%) and abdominal pain (69%). The mean duration of illness was 7.7±8.2 days, the mean 
duration of diarrhea was 5.2±8.4 days. Nine out of 270 individuals (3%, n=1 missing data on rectal 
bleeding) reported rectal blood loss. 
Fifty six fecal samples were collected from subjects clinically diagnosed with IGE of which 26 
specimens tested positive for an infectious pathogenic agent. Norovirus NoV GI.4, GII.4, GII.14, GII.7 
was most frequently detected (15/56), followed by Giardia lamblia (5/56), Campylobacter ssp. (4/56), 
adenovirus (1/56) and rotavirus A (1/56). Two patients were positive for more than 1 infectious 
agent: 1 with NoV GI.4 and GII.4, and 1 with Campylobacter jejuni and NoV GI.4 and GII.7. 
 
Risk factors underlying the susceptibility to develop IGE 
Participants were asked to provide information on their consumption and use of the drinking 
water. 39% of inhabitants drank tap water with an average of 3.7 glasses per day while almost all 
subjects used tap water to brush their teeth (98%) or to wash vegetables and fruit (97%).  
As previous studies indicated psychological factors as risk factor to develop PI-IBS, subjects 
were asked to complete the HADS and PHQ-12 questionnaires to assess anxiety, depression and 
somatization 2 and 4 weeks before the outbreak respectively. As shown in Fig. 3A, the proportion of 
subjects with abnormal anxiety scores (>10) was increased in the IGE group (11%) compared to the 
exposed group (4%, p χ2=0.0001). Also PHQ-12 somatization scores were increased in the IGE group 
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(median=3 IQR[2-7]) compared to the exposed group (median=2.5 IQR[1-5], Mann Whitney-U test 
p=0.0001). The proportion of subjects with abnormal depression scores was not different between 
the IGE (4%) and the exposed group (5%) (Fig. 3A). Of note, the prevalence of pre-existing dyspepsia-
like symptoms before the IGE outbreak was higher in the IGE group compared to the exposed group 
(35% vs 19% respectively; p χ2<0.0001). 
As shown in Table 1, univariate analyses revealed that the development of IGE was 
associated with gender, age, pre-existing dyspepsia-like symptoms and drinking contaminated tap 
water. Of interest, anxiety and PHQ12 somatization, but not depression scores, were significantly 
associated with the development of IGE (Table 1, Fig. 3A). Inclusion of the significant parameters in a 
multivariate binary logistic regression model identified age, pre-existing dyspepsia-like symptoms, 
drinking tap water and anxiety as independent risk factors to develop IGE (Table 1). 
Of interest, analysis of the risk factors to develop IGE based on only individuals with classic 
IGE (n=168) compared to the IGE- group (n=697) revealed very similar results (data not shown). 
 
Table 1. Risk factors to develop IGE  
 
 Total IGE+ IGE- 
Univariate 
Pearson χ
2
 
p  
OR [95% CI] 
Multiva
riate 
logistic 
regressi
on p 
OR [95% CI] 
Acute phase 968 271 697     
Female, N (%) 496 (51%) 156 (59%) 340 (49%) 0.015   NS  
Age, mean(SD) 52(16) 49 (16) 53 (16) <0.0001# 0.98[0.98-0.99] 0.001 0.98[0.97-0.99] 
Pre-existing dyspepsia-like 
symptoms, N (%) 
213 (22%) 93 (35%) 120 (19%) <0.0001 
 0.026 1.1[1.0-1.1] 
Exposure to tap water:        
Not reported, N (%)  87(32%) 2(0.3%)     
Drinking tap water, N (%)  104(57%) 242(35%) <0.0001  <0.0001 2.6[1.8-3.7] 
Psychological factors:        
anxiety HADS score (mean, 
95%CI] 
 5.29[4.78-
5.79] 
3.99[3.73-
4.25] 
<0.0001# 
1.1[1.1-1.2] 0.010 1.1[1.0-1.1] 
depression HADS score 
(mean, 95%CI] 
 3.37[2.95-
3.80] 
3.19[2.93-
3.45] 
0.62 
1.0[0.97-1.05]   
somatization score (PHQ-12) 
(mean, 95%CI] 
 4.50[4.05-
4.95] 
3.37[3.13-
3.62] 
<0.0001# 
1.1[1.06-1.14] NS  
        
# p binary logistic regression test, NS: not significant in multivariate analysis  
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Immune response in the infectious period and relationship with psychological factors 
To evaluate the relationship between psychological factors and the immune response to the 
infection, PBMCs were immunologically phenotyped in great detail, plasma cytokines were measured 
and the expression of inflammatory genes was studied in rectal biopsies. Plasma cytokine analysis of 
23 individuals with IGE (50±17 years, 15F, 17 classic, 5 moderate IGE, 1 IGE w/o diarrhea) and 16 
healthy controls (46±15 years, 9F) revealed no differences in cytokine levels for IFNγ, IL4, IL13, IL6, 
IL8, IL10, IL13 or IL17 (sFig.1). In contrast, inflammatory gene mRNA expression for IL10, TNFα, IL6, 
MCP-1 and IFNγ was significantly upregulated in rectal biopsies of 9 subjects with IGE (mean age 
44±16 years, 5F) compared to 9 healthy controls (mean age 54±17 years, 5F) (Fig. 3C). mRNA 
expression levels for IL4 and IL5 were below detection limit. 
Next, we evaluated the potential relationship between psychological factors and the immune 
response to the infectious pathogens in the total IGE group. The number of CD4+CD8-IL2+ T cells, a 
cell type critical in maintaining regulatory T cells (Treg)(31), was inversely correlated with anxiety, 
depression and somatization (Fig. 3B). The observed significances for CD4+CD8-IL2+ T cells did not 
survive FRD correction for multiple testing. There was no correlation between psychological scores 
and Tregs, Th1, Th2 or Th17 cells (data not shown).  
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B. One year follow-up 
Incidence of IBS and type of gastrointestinal symptoms: 
567 of the 968 (59%) participants returned the questionnaires 1 year after the outbreak, 
including 180/271 (66%) of the IGE group and 387/697 (56%) of the exposed subjects who did not 
develop IGE (Fig. 1). 29 subjects (8 IGE, 21 exposed) were excluded because of incomplete Rome 
questionnaires (Fig. 1). 19.8% (34/172) of IGE subjects developed IBS (IGE+IBS+, OR: 3.0[1.8-4.9]) 
compared to 6.6% (24/366) of the exposed group that did not develop IGE (IGE-IBS+, pχ2<0.0001). Of 
the PI-IBS patients, 24% had IBS-C, 35% IBS-D, 6% IBS-M and 35% IBS-U. The main gastrointestinal 
symptoms, assessed using the GSRS questionnaire, are shown in Supplemental Figure 2. Notably, IGE 
patients also developed more dyspeptic symptoms since the outbreak; 25% of IGE patients 
developed an abnormal dyspepsia-like symptom score compared to 14% in the exposed no-IGE 
group (pχ2<0.003, OR: 2.0 [1.3-3.3]). Demographic data on subjects who responded versus who did 
not at 1 year follow-up are reported in supplemental Table 4. 
 
Psychological factors and immune profile 1 year after the outbreak 
The proportion of subjects with an abnormal anxiety score was higher in the IGE subjects 
whether they did (IGE+IBS+ 12%) or did not develop IBS (IGE+IBS-, 9%) compared to the exposed 
group and in subjects that developed IBS but had no IGE (IGE-IBS+, 25%) compared to the group that 
did not develop IGE or IBS (exposed IBS-, 3%, p χ2<0.0001, Fig. 4A). PHQ-12 somatization scores were 
also increased in the PI-IBS- (median: 6 IQR[5-7]), PI-IBS+ (median: 5 IQR[5-6]) and exposed IBS+ 
(median=5.5 IQR[5-6]) groups compared to the exposed IBS- group (median=3 IQR[1-5], p Kruskal 
Wallis with Dunns’ correction for multiple comparisons) (Fig. 4A). In contrast, the proportion of 
subjects with abnormal depression scores was similar amongst groups (Fig. 4A). 
To evaluate the role of persistent immune activation in the development of PI-IBS, PBMC 
phenotypes and plasma cytokine levels were assessed in 108 individuals (for details, see 
Supplemental Table 2), including 17 PI-IBS+. CD4-CD19+ B cells were increased in IGE+IBS+ compared 
to exposed IBS- individuals (Fig. 4B). However, there were no differences in B cell subpopulations 
(sFig. 2), immuno-phenotypes of T cell populations, DCs or NK cells when comparing IGE+IBS+ with 
IGE+IBS- and IGE-IBS- subjects. When assessing cytokine levels in supernatants of stimulated PBMCs 
(n=77, supplemental Table 2), IL10 and IL-8 levels were increased in PI-IBS compared to the exposed 
group while IL13, IL1b and TNFα levels were similar in all groups (Fig. 4C). Plasma cytokine levels 
(IFNg, IL17, IL10, IL4, IL6, IL8 and IL13 were not different between IGE+IBS+ and IGE+IBS- or exposed 
groups (sFig. 4). None of the results could withstand Bonferroni multiple testing correction. 
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Finally, inflammatory cytokines mRNA was assessed in rectal mucosal biopsies of 32 subjects, 
including 9 IGE+IBS-, 5 IGE+IBS+, 15 IGE-IBS- and 3 IGE-IBS+ (sTable 3). There was no difference in 
mRNA expression level of IL10, IL6, IL8, TNFa nor hMCP-1 between IGE+IBS+, IGE+IBS- and exposed 
groups (sFig. 5). IFNγ and IL5 mRNA expression levels were below detection limits (Ct=35). 
 
Risk factors to develop PI-IBS  
As shown in Table 2, univariate analysis revealed that the development of PI-IBS after IGE is 
associated with anxiety, somatization and GSRS dyspepsia-like symptom scores, all prior to outbreak 
and at follow-up, together with age and IGE severity (number of diarrhea days, abdominal cramping). 
 
Table 2. Risk factors to develop PI-IBS after IGE 
 
 Total 
Self-reported 
IGE 
Exposed, no 
IGE 
Pearson χ
2
 p IGE 
vs no IGE 
 
1 year follow-up 538 172 366   
Female, N (%) 258 (48%) 92 (53%) 166 (45%) 0.08  
Age, mean (SD) 52 (15) 50 (15) 54 (15) 0.016#  
IBS, N (%) 58 (11%) 34 (20%) 24 (7%) <0.0001  
      
 PI-IBS IGE 
Univariate 
binary logistic 
regression test 
p 
Multivariate 
logistic 
regression p 
OR [95% CI] 
Risk factors PI-IBS acute phase      
Age, mean(SD) 42.4 (13.2) 52.0 (15.3) 0.002 0.010 0.95[0.91-0.99] 
Number of diarrhea days, mean 
(SD) 
7.8 (7.4) 4.7 (5.4) 0.03 NS  
Abdominal cramping   0.017 NS  
HADS anxiety   0.014 NS  
PHQ12  somatization    0.0001 0.008 1.16[1.03-1.31] 
Pre-existing dyspepsia-like 
symptoms 
  
0.013 NS 
 
Risk factors PI-IBS at 1 yr 
follow-up 
  
  
 
HADS anxiety   0.044 NS  
PHQ12  somatization    <0.0001 NS  
Dyspepsia-like symptoms   <0.0001 0.0001 1.17[1.05-1.30] 
      
# p binary logistic regression test, NS: not significant in multivariate analysis 
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 In contrast, the development of PI-IBS was not associated with gender, other IGE 
characteristics, drinking tap water or number of glasses water consumed per day, use of medication 
(antibiotics, anti-diarrhea, ORS), allergy (hay fever, eczema), asthma, atopic constitution, alcohol, 
smoking, drugs, or familial history of IBD/IBS, prior major depression or traumatic life time 
experience, depression at time of outbreak or at follow-up. The multivariate logistic regression 
model at the time of infection revealed age and somatization as risk factor to develop PI-IBS. 
Inclusion of the significant parameters at 1 year follow-up identified the presence of dyspepsia-like 
symptoms as independent factor associated with PI-IBS (Table 2).  
To study the relative contribution of psychological factors and IGE as risk factors to develop 
IBS, we performed an extra analysis on all subgroups (IGE-IBS-, IGE-IBS+, IGE+IBS- and IGE+IBS+). In 
line with our findings above, anxiety before the outbreak predicts IGE development (p=0.001, path b 
in Fig. 5A) and IBS at follow-up (p<0.0001, Fig. 5B) directly. When IGE status was added to the model 
in Fig. 5B, both anxiety (p<0.0001, path a’ in Fig. 5A) and IGE (p=0.0018, path c in Fig. 5A) were 
identified as predictors of IBS at follow-up, without the direct effect of anxiety being changed 
compared to the model in Fig. 5B. Therefore, the effect of anxiety on IBS at follow-up is not only 
direct but also to a limited though significant extent indirect through increasing vulnerability to IGE 
development. Similarly, somatization scores before the outbreak predicted IGE (p=0.0088, path b in 
Fig. 5C) and IBS (p< 0.0001, path a in Fig. 5D). In combination, both somatization (p<0.0001, path a’ in 
Fig. 5C) and IGE (path c in Fig. 5C) are significant predictors of IBS at follow-up, without the effect of 
somatization being significantly changed compared to the model in Fig. 5D. This indicates that the 
effect of somatization on IBS is not only direct, but also to a certain extent indirect through increased 
risk of IGE during the outbreak. 
Finally, depression before the outbreak predicts IBS (p=0.0038, path a in Fig. 5F) but not the 
development of IGE (p=0.15, path b in Fig. 5E). When IGE status was added to the model, both 
depression (p=0.0077, path a’ in Fig. 5E) and IGE (p=0.0002, path c in Fig. 5E) were predictors of IBS 
at follow-up, without the effect of depression being changed compared to F, suggesting that the 
effects of depression and IGE on the development of IBS are independent of each other. 
To evaluate if the acute immune response during the episode of IGE predicts the 
development of PI-IBS, the phenotype of the PBMCs of PI-IBS patients in the acute phase was 
compared with those who did not develop PI-IBS. Although the n-values are small, increased 
numbers of Th2 cells were observed at the time of IGE in individuals who went on to develop PI-IBS 
compared to those who did not (p=0.02, Mann Whitney U t-test, Fig. 6). There is also a trend towards 
decreased numbers of Th1 cells and CD4+CD8-IL2+ cells (p=0.07) during IGE in subjects who develop 
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PI-IBS 1 year later compared to those who do not (Fig. 6). Plasma cytokine levels (IFNg, IL17, IL10, IL4, 
IL6, IL8 and IL13) were not different (data not shown).   
 
DISCUSSION 
A large cohort exposed to contaminated drinking water was prospectively studied to assess 
the risk to develop PI-IBS, focusing on the role of psychological factors and the immune response 
both in the acute phase and 1 year after the outbreak. Our study indicates that IGE and psychological 
factors (anxiety and somatization but not depression) are associated with an increased risk to 
develop PI-IBS. Of interest though, we showed that anxiety and somatization are also risk factors to 
develop IGE, thereby indirectly adding to the increased risk to develop IBS. Thorough analysis of the 
immune response in the acute IGE phase revealed that anxiety was associated with a reduction in IL2 
expressing CD4+CD8-T cells, suggesting a link between psychological factors, immune response and 
the observed increased risk to develop IGE. Moreover, we found that patients who developed PI-IBS 
had a lower number of CD4+CD8- IL2+ T cells and Th1 cells but an increased number of Th2 cells at 
the time of infection. These data suggest that a predominant Th2 response against the infectious 
insult may predispose to progression to PI-IBS. The resolution of the systemic Th2 bias by one year 
follow-up is consistent with a shift in pathophysiology to the mucosa, and may explain why cohort 
studies have found conflicting results when determining whether IBS patients have a systemic Th2 
bias (14;32;33). Based on these findings, we propose that psychological factors, in particular anxiety 
and somatization, increase the risk to develop PI-IBS. This effect is to a certain extent explained by 
increasing the susceptibility to develop IGE, possibly by skewing the immune response towards a 
predominant Th2 response at the time of infection.  
An episode of infectious gastroenteritis is a well-defined risk factor to develop IBS (34). Here, 
we report on a large cohort of more than 18000 residents exposed to drinking water contaminated 
by creek water containing Norovirus, Campylobacter spp and Giardia lamblia. Of the 968 residents 
who participated, 28% developed symptoms of IGE. Similar to previous studies (8), IGE was 
associated with an increased risk (odds ratio of 3) to develop PI-IBS, i.e. 20% of IGE patients was 
identified as IBS compared to 7% in the exposed control group. This proportion is higher compared to 
the 8% reported following a food-borne outbreak with Salmonella (3), but lower than the 36% 
detected in the mixed waterborne outbreak of Walkerton (9). The proportion of IBS-C (35% in the PI-
IBS group compared to less than 10 % in literature) tends to be higher compared to previous studies 
(35;36). The explanation for this difference remains speculative but the type and localization of 
infection may be factors that determine the clinical phenotype. In addition to severity of IGE and age, 
and consistent with previous studies (2;12), psychological factors, in particular anxiety and 
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somatization, were identified as risk factors to develop IBS (37) and PI-IBS (2;12). A novel and 
intriguing finding, however, is that anxiety and somatization are also associated with an increased 
susceptibility to develop IGE. This observation suggests that the increased risk of subjects with 
increased anxiety and somatization to develop PI-IBS is partly explained by the observation that they 
are more susceptible for a gastrointestinal infection. To what extent this results from stress-induced 
impaired barrier function (38) or impaired immune function with hampered clearance of the 
infectious agent (25) is hard to investigate. Of note, age is protective against IGE and this may 
possibly be directly related to age or may be due to previous exposure. Moreover, at the time of 
infection, anxiety and depression were inversely correlated with the percentage of CD4+CD8- IL-2-
producing T cells in peripheral blood. In line, subjects with IGE who developed PI-IBS also had low 
numbers of CD4+CD8- IL-2+ T cells at the time of infection. Moreover, these individuals revealed a 
more Th2 skewed immune response during the infectious challenge, as evidence by increased Th2 
cells and reduced Th1 cells in the blood samples collected during the period of IGE. As IL-2 is an 
important Th1 cytokine and CD4+CD8-IL2+ T cells are involved in regulatory T cell biology and 
immune homeostasis (31), the reduction in CD4+IL-2+ T cells related to anxiety and depression may 
theoretically contribute to the increased susceptibility for infection and perhaps set the stage to 
develop PI-IBS. It should be emphasized though that the number of blood samples studied is low, and 
that this conclusion thus remains very speculative. Nevertheless, animal studies support the notion 
that psychological factors can drive the Th1/Th2 balance towards Th2 predominance (24), and 
thereby increase susceptibility to infection with enteropathogens (25). 
 Persistent mucosal microscopic inflammation with increased mast cells, lamina propria T cells 
and enterochromaffin cells has been demonstrated in intestinal biopsies collected from PI-IBS 
patients (2;13;39). In addition, Gwee et al. (13) showed increased IL-1beta expression in PI-IBS rectal 
biopsies taken 3 months after the infection. However, we failed to detect any changes in expression 
of pro-inflammatory cytokines in rectal biopsies of collected 1 year after infection. Similar findings 
were reported by Mearin et al (14) although it has to be emphasized that patients were studied three 
years after gastroenteritis. Our results may be explained by the fact that the infectious pathogens 
involved (noroviruses, Giardia lamblia and Campylobacter spp) do not infect the distal gut and thus 
may not induce long-term immunological changes in the rectum. However, we did find upregulation 
of pro-inflammatory cytokines in the acute infectious phase arguing against this possibility. 
Moreover, we recently found that submucosal neurons of rectal biopsies of IGE+IBS patients from 
this cohort were more sensitive to the TRPV1 agonist capsaicin compared to biopsies of the IGE+IBS- 
group (40). In line, Mearin et al. showed hypersensitivity to rectal distention in PI-IBS patients 
compared to infected patients who did not develop IBS, even though no differences were found in 
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rectal biopsies. Taken together, these data indicate that intestinal sensory function can indeed be 
affected by an episode of IGE, even in the absence of local persistent inflammation. 
To further evaluate the role of immune activation in PI-IBS, we also thoroughly phenotyped 
PBMCs and quantified plasma cytokine levels. Of interest, we found increased CD4-CD19+ B cell 
numbers in PI-IBS+ compared to PI-IBS- patients. Our finding that PI-IBS patients have a Th2 
predominant immune response at the time of infection, is compatible with the assumption that a 
humoral immune response could be involved in PI-IBS. This hypothesis is indirectly supported by 2 
recent studies in IBS patients showing increased activation of mucosal B lymphocytes and plasma 
cells in jejunal biopsies (41) and increased activation level of blood B cells (42). Similar to previous 
studies in IBS patients (43;44) we also found an increase in serum IL-8 levels, however, no other signs 
of aberrant immune activation in PI-IBS were observed. 
The major strength of our study is that we prospectively studied a community sample of 
exposed and infected subjects and assessed psychological and immunological factors in great detail 
both in the acute infectious phase and 1 year later. This allowed us to identify psychological factors 
not only as a risk factor to develop PI-IBS but also to unravel its impact on the susceptibility to 
develop IGE. Moreover, this is the first study reporting on the immune response during the period of 
IGE, albeit in a small group of subjects, and to relate this to the risk to develop PI-IBS 1 year later. The 
major weakness of the study is the relatively low sample size of rectal biopsies and blood samples, in 
particular in the acute infectious phase. As a result, some of our data do not withstand correction for 
multiple testing, and should be interpreted cautiously. Also, the low recruitment number may 
introduce some bias and therefore extrapolation of our data to a wider population should be done 
with caution. This low sample number is inherent to the fact that it is a prospective study and it is 
logistically difficult to recruit individuals during the acute period of the outbreak. Moreover, our 
study is limited by the fact that questionnaires on anxiety, depression and somatization before the 
infection were assessed in the acute infectious phase and we cannot exclude a recall bias due to 
gastrointestinal symptoms experienced due to the infection. In an attempt to circumvent this 
problem, we excluded questionnaires on gastrointestinal symptoms from the PHQ15 questionnaire.  
Altogether, our study shows that the increased risk of patients with psychological co-
morbidity to develop PI-IBS is partly due to an increased susceptibility to develop IGE. Moreover, we 
provide evidence to speculate that subjects who develop a predominant Th2 response against the 
infectious agent are prone to develop a humoral immune response and subsequently PI-IBS.  
 
 
 
Page 16 of 64
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
17 
 
CONFLICTS OF INTEREST 
The authors declare no conflict of interest 
 
AUTHOR CONTRIBUTIONS:  
All authors read and approved the final version of the manuscript. 
Mira M Wouters:  data acquisition, analysis and interpretation of data, writing and 
critical revision of the manuscript for important intellectual content 
Anh Nguyen: data acquisition, analysis and interpretation of data 
Sander JM van Wanrooij: study concept and design, acquisition of data, analysis and 
interpretation of data 
James Dooley: data acquisition 
Javier Aguilera-Lizarraga:  data acquisition 
Winde Vanbrabant:  recruitment of study subjects, data acquisition 
Josselyn E Garcia-Perez: d ta acquisition 
Lukas Van Oudenhove: statistical analysis, interpretation of data, critical revision of the 
manuscript for important intellectual content 
Marc Van Ranst:  data acquisition 
Jan Verhaegen:   data acquisition 
Adrian Liston: study supervision, obtaining funding, critical revision of the 
manuscript for important intellectual content 
Guy Boeckxstaens:  study supervision, obtaining funding, critical revision of the 
manuscript for important intellectual content 
FUNDING: GEB was funded by a governmental (Odysseus programme, G·0905·07) of the Research 
Foundation - Flanders (FWO) and university grant (Global Opportunities for Associations GOA 
14.011). MMW is supported by a FWO postdoctoral fellowship. This work was funded by FWO 
research grant G·0699·10N to GB and MMW. AL received the ERC Start grant IMMUNO. TLAN is 
funded by VIB International PhD program. 
TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT01497847 entitled “Post-Infectious Irritable Bowel 
Syndrome (PI-IBS)” 
  
Page 17 of 64
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
18 
 
FIGURE LEGENDS 
Figure 1. Flow chart of outbreak cohort 
Figure 2. Incidence of gastroenteritis   
Individuals who developed IGE between December 6 and 19 were included in the study. 
Figure 3. Prevalence of psychological conditions prior to infectious gastroenteritis and correlation 
with IL2 expressing T cells in acute infectious phase 
Panel A: Psychological status 2 weeks before the outbreak was assessed by HADS-anxiety and 
depression questionnaires and the PHQ12 somatization questionnaire. Panel B: HADS-anxiety, 
depression and somatization were inversely correlated with IL2 expressing CD4+ cells. Panel C: 
Relative mRNA expression levels of inflammatory genes in rectal biopsies were increased in subjects 
with IGE compared to non-infected, healthy volunteers (HV; relative expression to HPRT1 
housekeeping gene). Infected subjects suffered significantly more from increased anxiety and 
somatization compared to exposed subjects who would not develop symptoms of gastroenteritis (no 
IGE). 
Figure 4. Psychological factors, PBMC immunophenotypes and cytokine analysis of stimulated 
PBMCs at 1 year follow-up  
Panel A: HADS-anxiety and depression and PHQ12 somatization were assessed 1 year after the 
outbreak. Both IBS groups (IGE+IBS+ and IGE-IBS+) showed increased levels of anxiety and 
somatization compared to healthy individuals. Panel B: T cell phenotypes and B cell numbers were 
assessed and compared between subjects who developed IBS compared to subjects who did not.  
Only B cell numbers were significantly increased in PI-IBS patients compared to the exposed IBS- 
subjects. Panel C: Cytokine release of stimulated mononuclear leukocytes (PBMC) was assessed as a 
measure of their activation in vivo.  
PI NS: post-infectious no symptoms, * p<0.05; ** p<0.001; *** p<0.0001 
Figure 5. The effect of psychological factors on the susceptibility to develop infectious 
gastroenteritis and IBS symptoms 
The effect of anxiety, somatization and depression was assessed on the development of infectious 
gastroenteritis and IBS symptoms. Fig. A, C and E show the indirect effect of psychological factors on 
the development of IBS symptoms via increasing the vulnerability to gastroenteritis. Fig. B, C and F 
show the direct effect of psychological factors on the development of IBS symptoms. 
Figure 6. T helper cell analysis in the acute infectious phase comparing individuals who will develop 
PI-IBS compared to who will become symptom free 
Infected individuals who will develop PI-IBS (PI-IBS+) show a tendency for Th2 skewing towards the 
infectious pathogens as shown by increased Th2 numbers and a tendency toward decreased Th1 and 
CD4+CD8- IL expressing cells compared to infected individuals who will become symptom free (PI-
IBS-).  * p<0.05, Mann Whitney U t-test 
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ABSTRACT:  
Objective: Psychological factors increase the risk to develop post-infectious irritable bowel syndrome 
(PI-IBS), but the mechanisms involved are unclear. As stress affects the immune system, we 
investigated the potential interaction between psychological factors, the immune response against 
infectious gastroenteritis (IGE) and the development of IGE and PI-IBS in a large cohort exposed to 
contaminated drinking water. 
Design: 18620 people exposed to contaminated drinking water (Norovirus, Giardia lamblia, 
Campylobacter jejuni) were invited to participate in a prospective controlled cohort study. They were 
asked to complete questionnaires assessing demographic, psychological and clinical data during the 
outbreak and one y ar later. At both time points, in-depth immune function (peripheral blood and 
rectal biopsies) was studied in a subgroup of subjects. 
Results: 1379 subjects completed the questionnaires during the outbreak, of which 271 developed 
IGE. Risk factors for IGE included younger age, pre-existing dyspepsia-like symptoms, anxiety and 
drinking contaminated tap water. Anxiety scores before the outbreak inversely correlated with IL2-
expressing CD4+Tcells (r=0.6, p=0.01, n=23). At follow-up, 34 of 172 (20%) IGE subjects developed IBS 
compared to 24/366 exposed participants (7%, p<0.0001, χ2 test). A Th2 cytokine phenotype at time 
of infection was associated with increased risk for PI-IBS 1 year later. Except for increased B cell 
numbers, no evidence for systemic or rectal mucosal immune activation in PI-IBS was demonstrated 
at follow-up.  
Conclusion: Our study shows that the increased risk of patients with psychological co-morbidity to 
develop PI-IBS may partly result from an increased susceptibility to develop IGE, possibly resulting 
from a Th2-immune bias. 
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SUMMARY BOX: 
What is already known about this subject: 
- Up to 30% of individuals develop PI-IBS following infectious gastroenteritis 
- Psychological factors increase the susceptibility to develop PI-IBS 
- Psychological stress alters the T helper 1 and T helper 2 (Th1/Th2) immune balance 
What are the new findings:  
- Anxiety and somatization are risk factors to develop IGE 
- Psychological factors, in particular anxiety and somatization, increase the risk to develop PI-
IBS partly by a direct effect and partly indirect via increased susceptibility to develop IGE  
- Anxiety and depression at the time of infection may alter the Th1/Th2 immune balance, 
predisposing to PI-IBS   
- Except for increased B cell numbers, there was no evidence for persistent immune activation 
in blood or rectal biopsies of PI-IBS  
How might it impact on clinical practice in the foreseeable future? 
- Our results provide further insight in the pathogenesis of PI-IBS, underscoring the impact of 
psychological factors  
- The absence of inflammation in PI-IBS suggests that anti-inflammatory treatment with agents 
such as mesalazine are unlikely to be effective 
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INTRODUCTION:  
Acute infectious gastroenteritis (IGE) is a well-defined risk factor to develop irritable bowel 
syndrome (IBS), with 8-31% of patients developing post-infectious IBS (PI-IBS) (1-10). To date, 
persistent mucosal microscopic inflammation is proposed to underlie abnormal neuromuscular 
function contributing to altered bowel habits and increased abdominal pain (11). Increased number 
of mononuclear cells and higher levels of IL1β mRNA have indeed been reported in rectal biopsies 
collected 3 months to 1 year after IGE (12;13). In line, 3 months after a Campylobacter infection, 
Dunlop et al. (2) showed a small increase in enterochromaffin cells in PI-IBS patients compared to 
infected subjects who did not develop IBS. However, the number of lamina propria T cells was higher 
in patients with PI-IBS and post-infected controls compared to healthy volunteers. Moreover, no 
differences in T lymphocytes, mast cells or pro-inflammatory cytokines were detected between PI-IBS 
patients and infected control subjects three years after a Salmonella infection, although only PI-IBS 
patients were hypersensitive to rectal distention (14). Hence, the evidence supporting the hypothesis 
that chronic microscopic inflammation or immune activation is involved in PI-IBS is rather limited, 
confined to small patient numbers and mostly based on biopsies collected 3-4 months after the 
episode of IGE, and thus clearly deserves further study. Of note, the severity of the insult to the 
mucosa differs significantly between pathogens, most likely explaining why some studies still report 
inflammatory changes after 3-6 months and others do not. For example, Campylobacter jejuni 
produces a severe insult with mucosal ulceration while viruses rather produce a more transient 
inflammation without ulcerations. The risk to develop PI-IBS is not only determined by the nature of 
the pathogen, the severity of the infection, age and gender, but also by psychological factors (15). 
Anxiety, depression and fatigue are identified as risk factors for PI-IBS (16;17). Correspondingly, 
patients with a history of anxiety and depression have impaired recovery of PI-IBS during a six to 
eight year period of follow-up (17;18). How psychological factors may increase the risk to develop PI-
IBS however remains unclear. Of interest, it is becoming increasingly clear that brain-gut interactions 
may significantly modulate the intestinal immune system, and thus the immune response to a 
pathogen. Chronic psychological stress impairs the immune system by altering patterns of cytokine 
secretion, thereby increasing the vulnerability to infections (19;20). For example, chronic 
psychological stress in rats alters the immune response from antigen-induced oral tolerance to 
sensitization with a subsequent antigen-induced increase in inflammatory cells and mucosal 
permeability (21). Likewise, chronic stress alters the Th1/Th2 balance (21;22) and leads to an 
accumulation of myeloid-derived suppressor cells in the peripheral blood and bone marrow 
associated with immunosuppression (23).  Moreover, chronic stress in mice activates the IL-10/STAT3 
axis, thereby suppressing the production of pro-inflammatory cytokine IL-12 and inducing a shift of 
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Th1/Th2 cytokines toward a Th2 predominance (24). Interestingly, a decreased Th1 immune 
response has recently been shown to lead to increased susceptibility of mice to infection with the 
enteropathogenic Escherichia coli (25). Based on these findings, we hypothesized that psychological 
factors may increase the risk to develop PI-IBS by modulation of the immune response towards the 
gastrointestinal infection.  
In December 2010, two small villages in Belgium (Hemiksem and Schelle) suffered from a 
large community-wide multi-pathogen outbreak of gastroenteritis due to contamination of the tap 
water with water from a small creek (26). At least 18000 local residents were exposed to this 
contaminated water supply (26). In the present study, we aimed 1. to explore the potential 
relationship between psychological factors, the immune response in the acute infectious phase and 
the risk to develop infectious gastroenteritis and/or PI-IBS; and 2. to study in depth the potential role 
of persistent immune activation in those patients who developed PI-IBS. To this end, data were 
prospectively collected using questionnaires evaluating demographics and psychological data, 
exposure to tap water, bowel habits before and during the outbreak. Additionally, clinical symptoms 
and immune activation were assessed by validated questionnaires and quantification of cytokine 
expression in (stimulated) peripheral blood mononuclear cells, in plasma and in rectal biopsies 
respectively in the acute phase of the infection and after 1 year.  
 
MATERIAL AND METHODS: 
An epidemic outbreak of IGE occurred in Hemiksem and Schelle (Belgium) between December 6 and 
9 in 2010 by contamination of the municipal tap water with local creek water as reported by the 
Local Health Authority (26). Although not officially established, the contamination was most likely 
caused by a misconnection of hoses by fireman during fire extinction. From December 6 onwards, 
the 18 620 inhabitants of both villages were exposed to contaminated water before being alarmed at 
December 9 by the Local Health Authority. From December 9 onwards, the population was advised 
to stop drinking tap water. At December 10, a task force was set up in our unit to study the 
epidemiology and long-term outcome of the outbreak. The study protocol was approved by the 
Ethics Committee of the University Hospitals Leuven and all patients gave informed consent.  
 
Study design:  
In the acute phase (within 2 weeks), 603 subjects who consulted their general physician because of 
IGE were approached by phone. This subset of patients underwent a standardized interview, filled 
out questionnaires (details below) and was approached to provide blood samples for PBMC isolation, 
faecal samples and rectal biopsies. Based on questionnaires, data were collected on demographics 
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(age, gender), exposure to tap water, bowel habits before and during the outbreak (ROME-III and 
GSRS questionnaires) and IGE characteristics, including onset of symptoms, duration of diarrhea, 
severity of abdominal discomfort and use of antibiotics. Moreover, to assess their psychological 
profile, subjects were asked to fill out the Hospital Anxiety and Depression Scale (HADS) based on 
how the subject felt 2 weeks before the outbreak and the Patient Health Questionnaire (PHQ-15) 
based on how the subject felt 4 weeks before the infection. Demographic data on the different 
recruitment strategies are reported in supplemental Table 3. To avoid the possibility that gastro-
intestinal symptoms at the time of infection influenced recall somatization scores, we modified the 
PHQ-15 by excluding three gastrointestinal items to create the PHQ-12 Somatic Symptom (PHQ-12 
SS) scale (27). In addition, all households (n=7711) of the 2 affected villages were contacted by 
mailing within 3 months after the outbreak. Subjects were invited to participate in our study and to 
complete questionnaires as described above. Subjects were excluded when younger than 18 years, if 
they had pre-existing IBS, if symptoms of IGE started outside the 2 week period following the first 
day of drinking water contamination and if the Rome III questionnaire was incompletely answered. 
One year after the outbreak, all subjects who participated previously were re-contacted to assess the 
development of PI-IBS and were asked to complete the following questionnaires: ROME-III, GSRS, 
HADS and PHQ-12. In addition, patients were asked to provide blood samples for PBMC isolation, 
faecal samples and rectal biopsies. 
 
Outcome measure / definitions:  
IGE was defined as a period of self-reported acute gastrointestinal discomfort within 2 weeks after 
tap water contamination. The severity of diarrhea was classified as follows (28): Classic IGE was 
defined as passage of three or more unformed stools per 24 h with at least one accompanying 
symptom (nausea, vomiting, abdominal cramps or pain, fever, blood in stools). Moderate IGE was 
defined as passage of one or two unformed stools with at least one additional symptom. Mild IGE 
was defined as passage of one or two unformed stools without additional symptoms. Controls (no-
IGE) were subjects who were exposed but did not report symptoms of IGE. The severity of abdominal 
cramping and abdominal pain was scored as none, mild, moderate or severe. IBS and the different 
IBS subtypes were diagnosed according to the ROME III criteria (http://www.romecriteria.org/ 
assets/pdf/19_RomeIII_apA_885-898.pdf). Subjects who reported IBS symptoms or had been 
diagnosed with IBS prior to December 6th 2010 were excluded from the study. The incidence of 
dyspepsia-like symptoms was based on 5 GSRS questions, namely epigastric pain and discomfort, 
sucking sensation in the epigastrium, nausea, bloating and regurgitation. A subject was considered as 
dyspeptic when the summated score on these questions is larger than 4. Finally, a total HADS anxiety 
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or depression score from 0 to 7 was considered normal, 8 to 10 as borderline while scores above 10 
were considered to be abnormal (29;30). 
Statistical analysis, gene expression studies, PBMC immune-phenotyping and cytokine analysis in 
plasma and in supernatants of stimulated PBMCs are described in supplementary Material and 
Methods. 
RESULTS:    
Characterization of patient cohort: 
A. Early phase 
Patient cohort 
Between December 6
th
 and 9
th
 2010, 18620 residents in 7711 households in Hemiksem and 
Schelle were exposed to contaminated tap water and asked to participate in our study. 1379 subjects 
completed the questionnaires of which 411 individuals were excluded (Flowchart Fig. 1).  
Of the 968 eligible subjects, 271 (28%) reported IGE: 62% presented with classic IGE, 19% 
with moderate IGE and 19% with abdominal symptoms but without diarrhea (IGE w/o diarrhea). The 
number of IGE cases followed a steep incline from December 6 to 8
th
 and peaked on December 8
th
 
(Fig. 2). Other main IGE symptoms included nausea (reported by 54%), vomiting (61%), abdominal 
cramping (55%) and abdominal pain (69%). The mean duration of illness was 7.7±8.2 days, the mean 
duration of diarrhea was 5.2±8.4 days. Nine out of 270 individuals (3%, n=1 missing data on rectal 
bleeding) reported rectal blood loss. 
Fifty six fecal samples were collected from subjects clinically diagnosed with IGE of which 26 
specimens tested positive for an infectious pathogenic agent. Norovirus NoV GI.4, GII.4, GII.14, GII.7 
was most frequently detected (15/56), followed by Giardia lamblia (5/56), Campylobacter ssp. (4/56), 
adenovirus (1/56) and rotavirus A (1/56). Two patients were positive for more than 1 infectious 
agent: 1 with NoV GI.4 and GII.4, and 1 with Campylobacter jejuni and NoV GI.4 and GII.7. 
 
Risk factors underlying the susceptibility to develop IGE 
Participants were asked to provide information on their consumption and use of the drinking 
water. 39% of inhabitants drank tap water with an average of 3.7 glasses per day while almost all 
subjects used tap water to brush their teeth (98%) or to wash vegetables and fruit (97%).  
As previous studies indicated psychological factors as risk factor to develop PI-IBS, subjects 
were asked to complete the HADS and PHQ-12 questionnaires to assess anxiety, depression and 
somatization 2 and 4 weeks before the outbreak respectively. As shown in Fig. 3A, the proportion of 
subjects with abnormal anxiety scores (>10) was increased in the IGE group (11%) compared to the 
exposed group (4%, p χ2=0.0001). Also PHQ-12 somatization scores were increased in the IGE group 
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(median=3 IQR[2-7]) compared to the exposed group (median=2.5 IQR[1-5], Mann Whitney-U test 
p=0.0001). The proportion of subjects with abnormal depression scores was not different between 
the IGE (4%) and the exposed group (5%) (Fig. 3A). Of note, the prevalence of pre-existing dyspepsia-
like symptoms before the IGE outbreak was higher in the IGE group compared to the exposed group 
(35% vs 19% respectively; p χ2<0.0001). 
As shown in Table 1, univariate analyses revealed that the development of IGE was 
associated with gender, age, pre-existing dyspepsia-like symptoms and drinking contaminated tap 
water. Of interest, anxiety and PHQ12 somatization, but not depression scores, were significantly 
associated with the development of IGE (Table 1, Fig. 3A). Inclusion of the significant parameters in a 
multivariate binary logistic regression model identified age, pre-existing dyspepsia-like symptoms, 
drinking tap water and anxiety as independent risk factors to develop IGE (Table 1). 
Of interest, analysis of the risk factors to develop IGE based on only individuals with classic 
IGE (n=168) compared to the IGE- group (n=697) revealed very similar results (data not shown). 
 
Table 1. Risk factors to develop IGE  
 
 Total IGE+ IGE- 
Univariate 
Pearson χ
2
 
p  
OR [95% CI] 
Multiva
riate 
logistic 
regressi
on p 
OR [95% CI] 
Acute phase 968 271 697     
Female, N (%) 496 (51%) 156 (59%) 340 (49%) 0.015   NS  
Age, mean(SD) 52(16) 49 (16) 53 (16) <0.0001# 0.98[0.98-0.99] 0.001 0.98[0.97-0.99] 
Pre-existing dyspepsia-like 
symptoms, N (%) 
213 (22%) 93 (35%) 120 (19%) <0.0001 
 0.026 1.1[1.0-1.1] 
Exposure to tap water:        
Not reported, N (%)  87(32%) 2(0.3%)     
Drinking tap water, N (%)  104(57%) 242(35%) <0.0001  <0.0001 2.6[1.8-3.7] 
Psychological factors:        
anxiety HADS score (mean, 
95%CI] 
 5.29[4.78-
5.79] 
3.99[3.73-
4.25] 
<0.0001# 
1.1[1.1-1.2] 0.010 1.1[1.0-1.1] 
depression HADS score 
(mean, 95%CI] 
 3.37[2.95-
3.80] 
3.19[2.93-
3.45] 
0.62 
1.0[0.97-1.05]   
somatization score (PHQ-12) 
(mean, 95%CI] 
 4.50[4.05-
4.95] 
3.37[3.13-
3.62] 
<0.0001# 
1.1[1.06-1.14] NS  
        
# p binary logistic regression test, NS: not significant in multivariate analysis  
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Immune response in the infectious period and relationship with psychological factors 
To evaluate the relationship between psychological factors and the immune response to the 
infection, PBMCs were immunologically phenotyped in great detail, plasma cytokines were measured 
and the expression of inflammatory genes was studied in rectal biopsies. Plasma cytokine analysis of 
23 individuals with IGE (50±17 years, 15F, 17 classic, 5 moderate IGE, 1 IGE w/o diarrhea) and 16 
healthy controls (46±15 years, 9F) revealed no differences in cytokine levels for IFNγ, IL4, IL13, IL6, 
IL8, IL10, IL13 or IL17 (sFig.1). In contrast, inflammatory gene mRNA expression for IL10, TNFα, IL6, 
MCP-1 and IFNγ was significantly upregulated in rectal biopsies of 9 subjects with IGE (mean age 
44±16 years, 5F) compared to 9 healthy controls (mean age 54±17 years, 5F) (Fig. 3C). mRNA 
expression levels for IL4 and IL5 were below detection limit. 
Next, we evaluated the potential relationship between psychological factors and the immune 
response to the infectious pathogens in the total IGE group. The number of CD4+CD8-IL2+ T cells, a 
cell type critical in maintaining regulatory T cells (Treg)(31), was inversely correlated with anxiety, 
depression and somatization (Fig. 3B). The observed significances for CD4+CD8-IL2+ T cells did not 
survive FRD correction for multiple testing. There was no correlation between psychological scores 
and Tregs, Th1, Th2 or Th17 cells (data not shown).  
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B. One year follow-up 
Incidence of IBS and type of gastrointestinal symptoms: 
567 of the 968 (59%) participants returned the questionnaires 1 year after the outbreak, 
including 180/271 (66%) of the IGE group and 387/697 (56%) of the exposed subjects who did not 
develop IGE (Fig. 1). 29 subjects (8 IGE, 21 exposed) were excluded because of incomplete Rome 
questionnaires (Fig. 1). 19.8% (34/172) of IGE subjects developed IBS (IGE+IBS+, OR: 3.0[1.8-4.9]) 
compared to 6.6% (24/366) of the exposed group that did not develop IGE (IGE-IBS+, pχ2<0.0001). Of 
the PI-IBS patients, 24% had IBS-C, 35% IBS-D, 6% IBS-M and 35% IBS-U. The main gastrointestinal 
symptoms, assessed using the GSRS questionnaire, are shown in Supplemental Figure 2. Notably, IGE 
patients also developed more dyspeptic symptoms since the outbreak; 25% of IGE patients 
developed an abnormal dyspepsia-like symptom score compared to 14% in the exposed no-IGE 
group (pχ2<0.003, OR: 2.0 [1.3-3.3]). Demographic data on subjects who responded versus who did 
not at 1 year follow-up are reported in supplemental Table 4. 
 
Psychological factors and immune profile 1 year after the outbreak 
The proportion of subjects with an abnormal anxiety score was higher in the IGE subjects 
whether they did (IGE+IBS+ 12%) or did not develop IBS (IGE+IBS-, 9%) compared to the exposed 
group and in subjects that developed IBS but had no IGE (IGE-IBS+, 25%) compared to the group that 
did not develop IGE or IBS (exposed IBS-, 3%, p χ2<0.0001, Fig. 4A). PHQ-12 somatization scores were 
also increased in the PI-IBS- (median: 6 IQR[5-7]), PI-IBS+ (median: 5 IQR[5-6]) and exposed IBS+ 
(median=5.5 IQR[5-6]) groups compared to the exposed IBS- group (median=3 IQR[1-5], p Kruskal 
Wallis with Dunns’ correction for multiple comparisons) (Fig. 4A). In contrast, the proportion of 
subjects with abnormal depression scores was similar amongst groups (Fig. 4A). 
To evaluate the role of persistent immune activation in the development of PI-IBS, PBMC 
phenotypes and plasma cytokine levels were assessed in 108 individuals (for details, see 
Supplemental Table 2), including 17 PI-IBS+. CD4-CD19+ B cells were increased in IGE+IBS+ compared 
to exposed IBS- individuals (Fig. 4B). However, there were no differences in B cell subpopulations 
(sFig. 2), immuno-phenotypes of T cell populations, DCs or NK cells when comparing IGE+IBS+ with 
IGE+IBS- and IGE-IBS- subjects. When assessing cytokine levels in supernatants of stimulated PBMCs 
(n=77, supplemental Table 2), IL10 and IL-8 levels were increased in PI-IBS compared to the exposed 
group while IL13, IL1b and TNFα levels were similar in all groups (Fig. 4C). Plasma cytokine levels 
(IFNg, IL17, IL10, IL4, IL6, IL8 and IL13 were not different between IGE+IBS+ and IGE+IBS- or exposed 
groups (sFig. 4). None of the results could withstand Bonferroni multiple testing correction. 
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Finally, inflammatory cytokines mRNA was assessed in rectal mucosal biopsies of 32 subjects, 
including 9 IGE+IBS-, 5 IGE+IBS+, 15 IGE-IBS- and 3 IGE-IBS+ (sTable 3). There was no difference in 
mRNA expression level of IL10, IL6, IL8, TNFa nor hMCP-1 between IGE+IBS+, IGE+IBS- and exposed 
groups (sFig. 5). IFNγ and IL5 mRNA expression levels were below detection limits (Ct=35). 
 
Risk factors to develop PI-IBS  
As shown in Table 2, univariate analysis revealed that the development of PI-IBS after IGE is 
associated with anxiety, somatization and GSRS dyspepsia-like symptom scores, all prior to outbreak 
and at follow-up, together with age and IGE severity (number of diarrhea days, abdominal cramping). 
 
Table 2. Risk factors to develop PI-IBS after IGE 
 
 Total 
Self-reported 
IGE 
Exposed, no 
IGE 
Pearson χ
2
 p IGE 
vs no IGE 
 
1 year follow-up 538 172 366   
Female, N (%) 258 (48%) 92 (53%) 166 (45%) 0.08  
Age, mean (SD) 52 (15) 50 (15) 54 (15) 0.016#  
IBS, N (%) 58 (11%) 34 (20%) 24 (7%) <0.0001  
      
 PI-IBS IGE 
Univariate 
binary logistic 
regression test 
p 
Multivariate 
logistic 
regression p 
OR [95% CI] 
Risk factors PI-IBS acute phase      
Age, mean(SD) 42.4 (13.2) 52.0 (15.3) 0.002 0.010 0.95[0.91-0.99] 
Number of diarrhea days, mean 
(SD) 
7.8 (7.4) 4.7 (5.4) 0.03 NS  
Abdominal cramping   0.017 NS  
HADS anxiety   0.014 NS  
PHQ12  somatization    0.0001 0.008 1.16[1.03-1.31] 
Pre-existing dyspepsia-like 
symptoms 
  
0.013 NS 
 
Risk factors PI-IBS at 1 yr 
follow-up 
  
  
 
HADS anxiety   0.044 NS  
PHQ12  somatization    <0.0001 NS  
Dyspepsia-like symptoms   <0.0001 0.0001 1.17[1.05-1.30] 
      
# p binary logistic regression test, NS: not significant in multivariate analysis 
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 In contrast, the development of PI-IBS was not associated with gender, other IGE 
characteristics, drinking tap water or number of glasses water consumed per day, use of medication 
(antibiotics, anti-diarrhea, ORS), allergy (hay fever, eczema), asthma, atopic constitution, alcohol, 
smoking, drugs, or familial history of IBD/IBS, prior major depression or traumatic life time 
experience, depression at time of outbreak or at follow-up. The multivariate logistic regression 
model at the time of infection revealed age and somatization as risk factor to develop PI-IBS. 
Inclusion of the significant parameters at 1 year follow-up identified the presence of dyspepsia-like 
symptoms as independent factor associated with PI-IBS (Table 2).  
To study the relative contribution of psychological factors and IGE as risk factors to develop 
IBS, we performed an extra analysis on all subgroups (IGE-IBS-, IGE-IBS+, IGE+IBS- and IGE+IBS+). In 
line with our findings above, anxiety before the outbreak predicts IGE development (p=0.001, path b 
in Fig. 5A) and IBS at follow-up (p<0.0001, Fig. 5B) directly. When IGE status was added to the model 
in Fig. 5B, both anxiety (p<0.0001, path a’ in Fig. 5A) and IGE (p=0.0018, path c in Fig. 5A) were 
identified as predictors of IBS at follow-up, without the direct effect of anxiety being changed 
compared to the model in Fig. 5B. Therefore, the effect of anxiety on IBS at follow-up is not only 
direct but also to a limited though significant extent indirect through increasing vulnerability to IGE 
development. Similarly, somatization scores before the outbreak predicted IGE (p=0.0088, path b in 
Fig. 5C) and IBS (p< 0.0001, path a in Fig. 5D). In combination, both somatization (p<0.0001, path a’ in 
Fig. 5C) and IGE (path c in Fig. 5C) are significant predictors of IBS at follow-up, without the effect of 
somatization being significantly changed compared to the model in Fig. 5D. This indicates that the 
effect of somatization on IBS is not only direct, but also to a certain extent indirect through increased 
risk of IGE during the outbreak. 
Finally, depression before the outbreak predicts IBS (p=0.0038, path a in Fig. 5F) but not the 
development of IGE (p=0.15, path b in Fig. 5E). When IGE status was added to the model, both 
depression (p=0.0077, path a’ in Fig. 5E) and IGE (p=0.0002, path c in Fig. 5E) were predictors of IBS 
at follow-up, without the effect of depression being changed compared to F, suggesting that the 
effects of depression and IGE on the development of IBS are independent of each other. 
To evaluate if the acute immune response during the episode of IGE predicts the 
development of PI-IBS, the phenotype of the PBMCs of PI-IBS patients in the acute phase was 
compared with those who did not develop PI-IBS. Although the n-values are small, increased 
numbers of Th2 cells were observed at the time of IGE in individuals who went on to develop PI-IBS 
compared to those who did not (p=0.02, Mann Whitney U t-test, Fig. 6). There is also a trend towards 
decreased numbers of Th1 cells and CD4+CD8-IL2+ cells (p=0.07) during IGE in subjects who develop 
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PI-IBS 1 year later compared to those who do not (Fig. 6). Plasma cytokine levels (IFNg, IL17, IL10, IL4, 
IL6, IL8 and IL13) were not different (data not shown).   
 
DISCUSSION 
A large cohort exposed to contaminated drinking water was prospectively studied to assess 
the risk to develop PI-IBS, focusing on the role of psychological factors and the immune response 
both in the acute phase and 1 year after the outbreak. Our study indicates that IGE and psychological 
factors (anxiety and somatization but not depression) are associated with an increased risk to 
develop PI-IBS. Of interest though, we showed that anxiety and somatization are also risk factors to 
develop IGE, thereby indirectly adding to the increased risk to develop IBS. Thorough analysis of the 
immune response in the acute IGE phase revealed that anxiety was associated with a reduction in IL2 
expressing CD4+CD8-T cells, suggesting a link between psychological factors, immune response and 
the observed increased risk to develop IGE. Moreover, we found that patients who developed PI-IBS 
had a lower number of CD4+CD8- IL2+ T cells and Th1 cells but an increased number of Th2 cells at 
the time of infection. These data suggest that a predominant Th2 response against the infectious 
insult may predispose to progression to PI-IBS. The resolution of the systemic Th2 bias by one year 
follow-up is consistent with a shift in pathophysiology to the mucosa, and may explain why cohort 
studies have found conflicting results when determining whether IBS patients have a systemic Th2 
bias (14;32;33). Based on these findings, we propose that psychological factors, in particular anxiety 
and somatization, increase the risk to develop PI-IBS. This effect is to a certain extent explained by 
increasing the susceptibility to develop IGE, possibly by skewing the immune response towards a 
predominant Th2 response at the time of infection.  
An episode of infectious gastroenteritis is a well-defined risk factor to develop IBS (34). Here, 
we report on a large cohort of more than 18000 residents exposed to drinking water contaminated 
by creek water containing Norovirus, Campylobacter spp and Giardia lamblia. Of the 968 residents 
who participated, 28% developed symptoms of IGE. Similar to previous studies (8), IGE was 
associated with an increased risk (odds ratio of 3) to develop PI-IBS, i.e. 20% of IGE patients was 
identified as IBS compared to 7% in the exposed control group. This proportion is higher compared to 
the 8% reported following a food-borne outbreak with Salmonella (3), but lower than the 36% 
detected in the mixed waterborne outbreak of Walkerton (9). The proportion of IBS-C (35% in the PI-
IBS group compared to less than 10 % in literature) tends to be higher compared to previous studies 
(35;36). The explanation for this difference remains speculative but the type and localization of 
infection may be factors that determine the clinical phenotype. In addition to severity of IGE and age, 
and consistent with previous studies (2;12), psychological factors, in particular anxiety and 
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somatization, were identified as risk factors to develop IBS (37) and PI-IBS (2;12). A novel and 
intriguing finding, however, is that anxiety and somatization are also associated with an increased 
susceptibility to develop IGE. This observation suggests that the increased risk of subjects with 
increased anxiety and somatization to develop PI-IBS is partly explained by the observation that they 
are more susceptible for a gastrointestinal infection. To what extent this results from stress-induced 
impaired barrier function (38) or impaired immune function with hampered clearance of the 
infectious agent (25) is hard to investigate. Of note, age is protective against IGE and this may 
possibly be directly related to age or may be due to previous exposure. Moreover, at the time of 
infection, anxiety and depression were inversely correlated with the percentage of CD4+CD8- IL-2-
producing T cells in peripheral blood. In line, subjects with IGE who developed PI-IBS also had low 
numbers of CD4+CD8- IL-2+ T cells at the time of infection. Moreover, these individuals revealed a 
more Th2 skewed immune response during the infectious challenge, as evidence by increased Th2 
cells and reduced Th1 cells in the blood samples collected during the period of IGE. As IL-2 is an 
important Th1 cytokine and CD4+CD8-IL2+ T cells are involved in regulatory T cell biology and 
immune homeostasis (31), the reduction in CD4+IL-2+ T cells related to anxiety and depression may 
theoretically contribute to the increased susceptibility for infection and perhaps set the stage to 
develop PI-IBS. It should be emphasized though that the number of blood samples studied is low, and 
that this conclusion thus remains very speculative. Nevertheless, animal studies support the notion 
that psychological factors can drive the Th1/Th2 balance towards Th2 predominance (24), and 
thereby increase susceptibility to infection with enteropathogens (25). 
 Persistent mucosal microscopic inflammation with increased mast cells, lamina propria T cells 
and enterochromaffin cells has been demonstrated in intestinal biopsies collected from PI-IBS 
patients (2;13;39). In addition, Gwee et al. (13) showed increased IL-1beta expression in PI-IBS rectal 
biopsies taken 3 months after the infection. However, we failed to detect any changes in expression 
of pro-inflammatory cytokines in rectal biopsies of collected 1 year after infection. Similar findings 
were reported by Mearin et al (14) although it has to be emphasized that patients were studied three 
years after gastroenteritis. Our results may be explained by the fact that the infectious pathogens 
involved (noroviruses, Giardia lamblia and Campylobacter spp) do not infect the distal gut and thus 
may not induce long-term immunological changes in the rectum. However, we did find upregulation 
of pro-inflammatory cytokines in the acute infectious phase arguing against this possibility. 
Moreover, we recently found that submucosal neurons of rectal biopsies of IGE+IBS patients from 
this cohort were more sensitive to the TRPV1 agonist capsaicin compared to biopsies of the IGE+IBS- 
group (40). In line, Mearin et al. showed hypersensitivity to rectal distention in PI-IBS patients 
compared to infected patients who did not develop IBS, even though no differences were found in 
Page 37 of 64
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
16 
 
rectal biopsies. Taken together, these data indicate that intestinal sensory function can indeed be 
affected by an episode of IGE, even in the absence of local persistent inflammation. 
To further evaluate the role of immune activation in PI-IBS, we also thoroughly phenotyped 
PBMCs and quantified plasma cytokine levels. Of interest, we found increased CD4-CD19+ B cell 
numbers in PI-IBS+ compared to PI-IBS- patients. Our finding that PI-IBS patients have a Th2 
predominant immune response at the time of infection, is compatible with the assumption that a 
humoral immune response could be involved in PI-IBS. This hypothesis is indirectly supported by 2 
recent studies in IBS patients showing increased activation of mucosal B lymphocytes and plasma 
cells in jejunal biopsies (41) and increased activation level of blood B cells (42). Similar to previous 
studies in IBS patients (43;44) we also found an increase in serum IL-8 levels, however, no other signs 
of aberrant immune activation in PI-IBS were observed. 
The major strength of our study is that we prospectively studied a community sample of 
exposed and infected subjects and assessed psychological and immunological factors in great detail 
both in the acute infectious phase and 1 year later. This allowed us to identify psychological factors 
not only as a risk factor to develop PI-IBS but also to unravel its impact on the susceptibility to 
develop IGE. Moreover, this is the first study reporting on the immune response during the period of 
IGE, albeit in a small group of subjects, and to relate this to the risk to develop PI-IBS 1 year later. The 
major weakness of the study is the relatively low sample size of rectal biopsies and blood samples, in 
particular in the acute infectious phase. As a result, some of our data do not withstand correction for 
multiple testing, and should be interpreted cautiously. Also, the low recruitment number may 
introduce some bias and therefore extrapolation of our data to a wider population should be done 
with caution. This low sample number is inherent to the fact that it is a prospective study and it is 
logistically difficult to recruit individuals during the acute period of the outbreak. Moreover, our 
study is limited by the fact that questionnaires on anxiety, depression and somatization before the 
infection were assessed in the acute infectious phase and we cannot exclude a recall bias due to 
gastrointestinal symptoms experienced due to the infection. In an attempt to circumvent this 
problem, we excluded questionnaires on gastrointestinal symptoms from the PHQ15 questionnaire.  
Altogether, our study shows that the increased risk of patients with psychological co-
morbidity to develop PI-IBS is partly due to an increased susceptibility to develop IGE. Moreover, we 
provide evidence to speculate that subjects who develop a predominant Th2 response against the 
infectious agent are prone to develop a humoral immune response and subsequently PI-IBS.  
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FIGURE LEGENDS 
Figure 1. Flow chart of outbreak cohort 
Figure 2. Incidence of gastroenteritis   
Individuals who developed IGE between December 6 and 19 were included in the study. 
Figure 3. Prevalence of psychological conditions prior to infectious gastroenteritis and correlation 
with IL2 expressing T cells in acute infectious phase 
Panel A: Psychological status 2 weeks before the outbreak was assessed by HADS-anxiety and 
depression questionnaires and the PHQ12 somatization questionnaire. Panel B: HADS-anxiety, 
depression and somatization were inversely correlated with IL2 expressing CD4+ cells. Panel C: 
Relative mRNA expression levels of inflammatory genes in rectal biopsies were increased in subjects 
with IGE compared to non-infected, healthy volunteers (HV; relative expression to HPRT1 
housekeeping gene). Infected subjects suffered significantly more from increased anxiety and 
somatization compared to exposed subjects who would not develop symptoms of gastroenteritis (no 
IGE). 
Figure 4. Psychological factors, PBMC immunophenotypes and cytokine analysis of stimulated 
PBMCs at 1 year follow-up  
Panel A: HADS-anxiety and depression and PHQ12 somatization were assessed 1 year after the 
outbreak. Both IBS groups (IGE+IBS+ and IGE-IBS+) showed increased levels of anxiety and 
somatization compared to healthy individuals. Panel B: T cell phenotypes and B cell numbers were 
assessed and compared between subjects who developed IBS compared to subjects who did not.  
Only B cell numbers were significantly increased in PI-IBS patients compared to the exposed IBS- 
subjects. Panel C: Cytokine release of stimulated mononuclear leukocytes (PBMC) was assessed as a 
measure of their activation in vivo.  
PI NS: post-infectious no symptoms, * p<0.05; ** p<0.001; *** p<0.0001 
Figure 5. The effect of psychological factors on the susceptibility to develop infectious 
gastroenteritis and IBS symptoms 
The effect of anxiety, somatization and depression was assessed on the development of infectious 
gastroenteritis and IBS symptoms. Fig. A, C and E show the indirect effect of psychological factors on 
the development of IBS symptoms via increasing the vulnerability to gastroenteritis. Fig. B, C and F 
show the direct effect of psychological factors on the development of IBS symptoms. 
Figure 6. T helper cell analysis in the acute infectious phase comparing individuals who will develop 
PI-IBS compared to who will become symptom free 
Infected individuals who will develop PI-IBS (PI-IBS+) show a tendency for Th2 skewing towards the 
infectious pathogens as shown by increased Th2 numbers and a tendency toward decreased Th1 and 
CD4+CD8- IL expressing cells compared to infected individuals who will become symptom free (PI-
IBS-).  * p<0.05, Mann Whitney U t-test 
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Supplementary material and methods 
Gene expression studies 
Total RNA was extracted by RNeasy Minikit (Qiagen Benelux, Antwerp, Belgium) and reverse 
transcribed by qScript cDNA Supermix (Quanta Science, Gaithersburg, MD, USA) according to the 
manufacturer’s instructions. Real-time PCR was performed on a LightCycler® 96 Real-Time PCR 
System (Roche Applied Science, Vilvoorde, Belgium) using the Lightcycler96 probes master mix as 
indicated by the manufacturer. Primer and probe sequences are described in supplemental Table 1. 
The relative expression of the target gene was calculated relative to the HPRT1 reference mRNA (1). 
 
Supplemental Table 1. Primer and probe sequences for quantitative PCR 
 
  
Gene Forward (5'-3' ) Reverse (5'-3') probe (5'-3')   
HPRT1 TAAGATGAGAGTTCAAGTTG GCAAATAAACAGTTTAGGAAT TCCTATTGACATCGCCAGTAA   
IFNγ ACGAGATGACTTCGAAAA TTCGCTTCCCTGTTTTAG CGGTAACTGACTTGAATGTCCAACG   
IL5 CAAGGACCTGCTGTATTC GCCTATTGTAGACAGTAAAATAAA
G 
AATGAACAAGCAGGCACTTACAACA   
IL10 AAGCCATGAGTGAGTTTG GTCCTAGAGTCTATAGAGTCG CGTATCTTCATTGTCATGTAGGCTTCT   
TNFα GACGAACATCCAACCTTC GGTGGTCTTGTTGCTTAA CCCCTGCCCCAATCCCTTTA   
IL6 TCTGGATTCAATGAGGAG CTGGATCAGGACTTTTGTA CTGGCTTGTTCCTCACTACTCTCA   
IL8 AGAGGGCTGAGAATTCATAA CACACAATACATGAAGTGTTGAA CACTGGCATCTTCACTGATTCTTGG   
MCP1 CCCCAGTCACCTGCTGTTAT TCCTGAACCCACTTCTGCTT ATTGTGGCCAAGGAGATCTG   
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Supplemental Table 2. Demographics of individuals who donated samples in 2012  
 PI-IBS- PI-IBS+ Exposed-IBS- Exposed-IBS+ 
PBMC’s and plasma 42 17 44 5 
Female, N (%) 22 (52%) 15 (88%) 20 (45%) 1 (20%) 
Age, mean (SD) 55 (14) 55 (14) 57 (13) 57 (13) 
Classic diarrhea 27 10   
Moderate diarrhea 8 3   
IGE w/o diarrhea 7 3   
Unknown IGE type  1   
Stimulated PBMC 
supernatants 
33 13 27 4 
Female, N (%) 17 (52%) 12 (92%) 15 (56%) 1 (25%) 
Age, mean (SD) 55 (15) 55 (15) 55 (15) 55 (15) 
Classic diarrhea 24 7   
Moderate diarrhea 6 3   
IGE w/o diarrhea 3 3   
Rectal biopsies 9 5 15 3 
Female, N (%) 3 (30%) 4 (80%) 5 (30%) 1 (33%) 
Age, mean (SD) 52 (13) 42 (14) 59 (13) 60 (13) 
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Supplemental Table 3. Demographics of individuals included in acute infectious phase through GP versus 
survey 
 
 IGE+ 
Recruited via GP 
IGE- IGE+ 
By questionnaires 
P IGE+ GP vs 
IGE+ survey 
n 102 697 169  
Female gender (N, %) 62(61%) 340(49%) 94(56%) 0.45 ♯ 
Age (years±SD) 52±17 53±16 48±15 0.159 * 
Number of diarrhea days, 
mean (SD) 
5±5  5±10 0.281 * 
Number of days with 
abdominal discomfort  
7±5  8±10 0.0001 * 
Classic IGE, N(%) 
Moderate IGE, N(%) 
IGE without diarrhea, 
N(%) 
Missing data, N(%) 
74(73%) 
18(18%) 
8(8%) 
 
1(1%) 
 94(56%) 
32(19%) 
41(24%) 
 
2(1%) 
0.0066 ♯ 
Blood in stool 2(2%)  7(4%) 0.40 ♯ 
Fever, N(%) 20(20%)  32(19%) 0.88 ♯ 
Abnormal anxiety (n,%) 10(10%) 29(4%) 19(11%) 0.417 ♯ 
Abnormal depression 
(n,%) 
6(6%) 32(5%) 5(3%) 0.320 ♯ 
PHQ-12 (mean±SD) 5±4 3±3 4±4 0.583 * 
IBS (n IBS/n total subjects 
at follow-up,%) 
14/68(21%) 24/365(7%) 20/104(19%) 0.827 ♯ 
 
♯P Fishers exact test, * Mann Whitney U test 
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Supplemental Table 4: Demographic data on subjects who responded versus who did not at 1 year follow-
up  
 
 
 No follow-up data Follow-up data Pχ2 or P Whitney U test 
N 400 568  
Female, N (%) 222(56%) 274(48%) 0.026 
Age, mean±SD 51±17 53±16 0.037 
IGE+ 90(23%) 181(32%) 0.0014 
Classic IGE 51(13%) 117(21%) 0.0015 
Abnormal anxiety 27(7%) 31(5%) 0.404 
Abnormal depression 21(5%) 22(4%) 0.306 
PHQ12 mean±SD 3.78±3053 3.64±3.26 0.105 
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PBMC Immune-phenotyping 
Whole blood was collected following a protocol approved by the Ethics Committee of the University 
Hospital Leuven. Heparinized blood was rested for 2 hours at 18˚C before extraction using ficoll 
separation protocol (LSM; MP Biomedicals, Belgium). PBMCs were frozen immediately in 10% 
Dimethylsulfoxide (DMSO, Sigma-Aldrich, Diegem, Belgium) 90% fetal bovine serum (FBS) at -80˚C for 
a maximum of 2 months.  
Thawed cells were stained using antibodies (purchased from eBiosciences, Vienna, Austria, unless 
mentioned elsewise) against CD3 (SK7), CD4 (RPA-T4), CD8α (RPA-T8), CD14 (61D3), CD19 (HIB19), 
CD25 (BC96), DC56 (MEM188), CD11c (3,9), CD123 (6H6), CD45Ra (HI100), CD31 (WM-59), CCR7 
(3D12), HLADR (LN3), Vα24Jα18 (6B11), CXCR5 (IgG23, R&D) to identify CD4 T cell subsets (naïve, 
RTE, TEM, TCM, Th1, Th2, Th17, Tfh, IL-2-producing, Tregs), CD8+ T cell subsets (naïve, RTE, IFNγ-
producing, IL-2 producing), B cell subsets (Naive, switched, memory- B cells), γδ T cells, DC, NK and  
NKT. Intracellular staining was performed for Foxp3 (206D, Biolegend, ImTec Diagnostics N.V., 
Antwerp, Belgium) using the eBioscience fix/perm buffers. Intracellular cytokine expression was 
measured following 5 hour stimulation at 37˚C with Phorbol myristate acetate (PMA, 50 µg/ml, 
Sigma-Aldrich) and Ionomycin (500 ng/ml, Sigma-Aldrich) in RPMI1620 in the presence of Golgistop 
(1:250, from BD kit). Following stimulation, cells were treated with BD fixative and permeabilisation 
buffers and stained for IFNγ (4S.B3), IL-4 (8D4-8), IL-17 (64DEC17) and IL-2 (MQ1-17H12). Acquisition 
was performed on a BD FACSCantoII with analysis by Flowjo (version 7.6.5, Ashland Or, USA).   
 
Cytokine analysis in supernatants of stimulated PBMCs 
Freshly isolated PBMCs were stimulated for 72 hour at 37˚C and 5% CO2 with CD3/CD28 (Sigma-
Aldrich). PBMC supernatant was collected and stored at -80°C until analysis. Cytokine levels of IL13, 
IL8, IL1b, IL10 and TNFα were quantified by cytometric bead array (BD Bioscience, Erembodegem, 
Belgium). Samples were acquired on FACSCanto flow cytometer (BD Bioscience) and analysed by 
FCAP v3.0 analysis software (Soft Flow Inc., Pecs, Hungary).  
 
Cytokine analysis in plasma 
Plasma was prepared by centrifuging whole blood at 300g for 15 min at 18°C and stored at -80°C 
until assay. The levels of soluble IL-4, IL-6, IL-8, IL-10, IL-13, IL-17 and IFNγ in thawed plasma was 
assessed by a Multi-spot assay system (V-plex kit: Cytokine and Proinflammatory Panel 1 Kits, 
Mesoscale Diagnostics) according to manufacturer’s instruction (Meso Scale Discovery (MSD) 
Rockville, MD, USA). The outcome signals were read by Sector Imager 2400 (MSD). 
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Statistical analysis 
All statistical analyses of the clinical data were performed using SPSS, version 22 (IBM, SPSS 
software, Belgium). Continuous data were summarized by their mean and standard deviation. When 
serious deviations from normality were observed, medians and interquartile values were presented. 
For categorical variables, observed frequencies and percentages were presented. Comparisons 
between groups were made using a Pearson Fisher exact or Chi-square test (reported as pχ2) when 
appropriate. Continuous variables such as age in relation to binary variables (IGE, PI-IBS) were 
analyzed by binary logistic regression analysis (reported as pLR). Variables identified to be associated 
with risk IGE or PI-IBS in univariate analyses were included in the multivariable logistic model. As 
simulation models have shown that regression coefficients and other indicators of risk may be 
unreliable if fewer than 10 events are included in the models, a ratio of 10 IBS cases per predictor 
variable was required to ensure model stability (2). Beta regression coefficients, odds ratios, and 
their corresponding 95% confidence interval (CI) for the multivariate model were reported with the 
criterion for statistical significance set a priori at 0.05. Multicollinearity was considered to be 
significant if the variance inflation factor exceeded 10. 
To test the relative contribution of psychological status at the moment of the outbreak 
(anxiety, depression, somatization) and development of IGE to the risk of developing IBS at follow-up 
in general, and, more specifically, test whether the effect of psychological variables on the risk of 
developing IBS at follow-up is direct or indirect through an increased risk of development of IGE, 
mediation analysis was performed (3) using SAS 9.4 software (SAS Institute, Cary, NC, USA). 
Mediation analyses requires estimating three regression equations (3): 1) (logistic) regression of the 
psychological variable (independent variable) on IBS status at follow-up (dependent variable); 2) 
(logistic) regression of the psychological variable (independent variable) on IGE status (mediator) and 
3) (logistic) regression of both the psychological variable (independent variable) and IGE status 
(mediator) on IBS status at follow-up (dependent variable). The effect of the psychological variable 
on IBS status at follow-up would be totally mediated through IGE status if adding IGE (in model 3) 
renders the (significant) effect of the psychological variable on IBS status (from model 1) non-
significant. 
All statistical analyses of the samples were performed using Graphpad Prism (Prism 6, version 
6.02, Graphpad Software, CA, USA). Normality of the data was checked by D´s Agostino and Pearson 
omnibus normality test. Non-parametric data were compared by Man-Whitney test or the Kruskal-
Wallis test followed by Dunn’s correction for multiple comparisons when appropriate. Significant 
values were set at p<0.05. For linear correlation, p and R2 values were calculated using Pearson 
correlation test. 
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Non-metric multidimensional scaling was used to visualize dissimilarities of samples between 
treatments. The ordination was created in R 3.1.0 using R-package vegan with custom scripts. 
Distance matrix was calculated with Bray-Curtis dissimilarity index on original data. To test for the 
contribution of each variable to the resulting distance matrix, we applied Mantel test in which the 
original distance matrix was compared with a temporary distance matrix where one variable (cell 
subset) was removed at a time. The test was run with 999 permutations.  
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Supplementary figure legends: 
sFig. 1.  Serum cytokine levels in acute infectious phase  
Serum cytokine levels were assessed in the acute infectious phase in subject who will become 
symptom free (IGE+ IBS-) or will develop PI-IBS (IGE+ IBS+) at 1 year follow-up. Cytokine levels were 
not different when comparing subjects suffering from acute gastroenteritis with healthy volunteers 
(HV). Moreover, there was no difference in serum cytokine level when comparing subjects who will 
develop IBS compared to those who will not. 
sFig. 2. Analysis of gastrointestinal symptoms in post-infectious and new-onset IBS patients 
compared to healthy individuals, 1 year after the outbreak 
Mean GSRS score per question (1-15) and total GSRS score (SUM) are presented on X axis for post-
infected no symptoms group (IGE+IBS-), post-infectious IBS (IGE+IBS+), the exposed group (IGE-IBS-) 
and the new-onset IBS group (IGE-IBS+). * p<0.05; ** p<0.001; *** p<0.0001 Kruskal Wallis test with 
Dunn’s multiple testing correction   
sFig. 3. PBMC phenotyping analysis 1 year follow-up  
Phenotypes of immune cells (B cells and subgroups, DC cells and subgroups and T cells) are not 
different between PI-IBS (IGE+IBS+), new onset IBS (IGE-IBS+), and their respective control groups 
(IGE+IBS- and IGE-IBS-). 
sFig. 4. Plasma cytokine analysis 1 year follow-up 
One year after the outbreak, cytokine levels are assessed in plasma. There are no differences in 
plasma cytokine levels for IL17, IFNg, IL10, IL4, IL6, IL8 or IL13 when comparing PI-IBS (IGE+IBS+), new 
onset IBS (IGE-IBS+), and their respective control groups (IGE+IBS- and IGE-IBS-). 
sFig. 5. One year follow-up inflammatory mRNA expression in rectal biopsies  
One year after the outbreak, mRNA expression levels of inflammatory genes were assessed in rectal 
biopsies. There are no differences in inflammatory gene expression levels in rectal biopsies when 
comparing PI-IBS (IGE+IBS+), new onset IBS (IGE-IBS+), and their respective control groups (IGE+IBS- 
and IGE-IBS-). 
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Serum cytokine levels in acute infectious phase  
 
Serum cytokine levels were assessed in the acute infectious phase in subject who will become symptom free 
(IGE+ IBS-) or will develop PI-IBS (IGE+ IBS+) at 1 year follow-up. Cytokine levels were not different when 
comparing subjects suffering from acute gastroenteritis with healthy volunteers (HV). Moreover, there was 
no difference in serum cytokine level when comparing subjects who will develop IBS compared to those who 
will not.  
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Analysis of gastrointestinal symptoms in post-infectious and new-onset IBS patients compared to healthy 
individuals, 1 year after the outbreak  
 
Mean GSRS score per question (1-15) and total GSRS score (SUM) are presented on X axis for post-infected 
no symptoms group (IGE+IBS-), post-infectious IBS (IGE+IBS+), the exposed group (IGE-IBS-) and the 
new-onset IBS group (IGE-IBS+). * p<0.05; ** p<0.001; *** p<0.0001 Kruskal Wallis test with Dunn’s 
multiple testing correction    
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PBMC phenotyping analysis 1 year follow-up  
 
Phenotypes of immune cells (B cells and subgroups, DC cells and subgroups and T cells) are not different 
between PI-IBS (IGE+IBS+), new onset IBS (IGE-IBS+), and their respective control groups (IGE+IBS- and 
IGE-IBS-).  
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Plasma cytokine analysis 1 year follow-up  
 
One year after the outbreak, cytokine levels are assessed in plasma. There are no differences in plasma 
cytokine levels for IL17, IFNg, IL10, IL4, IL6, IL8 or IL13 when comparing PI-IBS (IGE+IBS+), new onset 
IBS (IGE-IBS+), and their respective control groups (IGE+IBS- and IGE-IBS-).  
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One year follow-up inflammatory mRNA expression in rectal biopsies  
 
One year after the outbreak, mRNA expression levels of inflammatory genes were assessed in rectal 
biopsies. There are no differences in inflammatory gene expression levels in rectal biopsies when comparing 
PI-IBS (IGE+IBS+), new onset IBS (IGE-IBS+), and their respective control groups (IGE+IBS- and IGE-
IBS-).  
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